New research suggests that an “often-overlooked” parasitic infection, already linked to bladder cancer, may also raise the risk of cervical cancer.

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

Breakthrough for bladder cancer patients as tablet treatment rolled out on NHS - Hundreds will benefit after the first ...

Hundreds of patients are expected to benefit from the recommendation by the National Institute of Health and Care Excellence.

Bavencio as first-line maintenance was associated with long-term efficacy in advanced urothelial carcinoma regardless of ...

To grow, cancer tumors must hijack the immune system for their needs. One of the main tricks that most tumors use is to ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration ...

Health disparities lead to delayed diagnosis of these seven cancer types in the Black community, but awareness and early screening can help save lives.

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods ...

The drug, recommended by NICE, works by blocking certain proteins to slow down or stop the growth of cancer cells ...

Erdafitinib, also known as Balversa and made by Johnson & Johnson, is recommended in final draft guidance for adults with metastatic or unresectable FGFR-altered urothelial cancer who have previously ...